Relay Therapeutics, Inc. (RLAY)

Relay Therapeutics Revenue

Relay Therapeutics had revenue of $7.68M in the quarter ending March 31, 2025, a decrease of -23.26%. This brings the company's revenue in the last twelve months to $7.68M, down -78.26% year-over-year. In the year 2024, Relay Therapeutics had annual revenue of $10.01M, down -60.83%.

• Revenue (ttm): $7.68M
• Revenue Growth: -78.26%
• P/S Ratio: 65.52
• Revenue / Employee: $29,421
• Employees: 261
• Market Cap: 565.77M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	10.01M	-15.54M	-60.83%
Dec 31, 2023	25.55M	24.17M	1,749.82%
Dec 31, 2022	1.38M	-1.65M	-54.41%
Dec 31, 2021	3.03M	-79.63M	-96.34%
Dec 31, 2020	82.65M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.